Jennifer Schranz

With over 27 years of experience in leading high-performing teams across biotechnology and pharmaceutical industries, Jennifer specializes in global product clinical development and medical affairs, spanning a broad range of therapeutic areas. Her career is distinguished by her innovative work in rare and ultra-rare diseases, utilizing both traditional and novel approaches to clinical development, particularly in the areas of small molecules, biologics, and vaccines. Before entering the pharmaceutical industry, Jennifer trained as a physician in internal medicine and infectious diseases with a focus on HIV/AIDS, at the University of Toronto, Canada, and SUNY Stonybrook, New York. Currently, as Senior Vice President and Global Head of Rare Diseases at Ipsen, Jennifer leads a multidisciplinary team of scientists and clinicians focused on transforming the treatment of rare and underserved conditions. Ipsen's rare disease portfolio includes groundbreaking work in ultra-rare bone disorders